Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response

by Jeremy Z. R. Han, Jordan F. Hastings, Monica Phimmachanh, Dirk Fey, Walter Kolch, David R. Croucher
Published 2021-05-01

The under-appreciated promiscuity of the epidermal growth factor receptor family.

by Sean P Kennedy, Jordan F Hastings, Jeremy Z.R. Han, David R Croucher, David R Croucher, David R Croucher
Published 2016-08-01

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma

by Monica Phimmachanh, Jeremy Z. R. Han, Yolande E. I. O’Donnell, Sharissa L. Latham, Sharissa L. Latham, David R. Croucher, David R. Croucher
Published 2020-10-01

Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer

by Sean P. Kennedy, Jeremy Z. R. Han, Neil Portman, Max Nobis, Jordan F. Hastings, Kendelle J. Murphy, Sharissa L. Latham, Antonia L. Cadell, Dushan Miladinovic, Gabriella R. Marriott, Yolande E. I. O’Donnell, Robert F. Shearer, James T. Williams, Amaya Garcia Munoz, Thomas R. Cox, D. Neil Watkins, Darren N. Saunders, Paul Timpson, Elgene Lim, Walter Kolch, David R. Croucher
Published 2019-03-01